Navigation Links
Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Date:1/29/2008

WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference being held at the Grand Hyatt Hotel in New York City. The company will present on Thursday, February 7, 2008, at 9:20 am (EST).

Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific, will provide an overview of the company and discuss its expectations for future financial performance.

You may listen to the presentation live on our Website, http://www.thermofisher.com, by clicking on "Investors." An audio archive of the Webcast will be available in that section of our Website under "Webcasts and Presentations" through Friday, March 7, 2008.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com.

Media Contact Information:

Karen Kirkwood

Phone: 781-622-1306

E-mail: Karen.Kirkwood@thermofisher.com

Investor Contact Information:

Ken Apicerno

Phone: 781-622-1111

E-mail: ken.apicerno@thermofisher.com

Website: http://www.thermofisher.com


'/>"/>
SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
2. Thermo Fisher Scientific to Present at Investor Conferences
3. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
4. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
5. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
6. Thermo Fisher Scientific to Present at Upcoming Investor Conferences
7. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
8. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
9. Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, October 25, 2007
10. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies
11. Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life , ... in blood, has been named as a partner in Medigen Biotech’s upcoming cell ... therapies for cancer treatment, will use CellMax Life’s circulating tumor cell platform CMxTM, ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT , ... biosciences ventures invited to participate in the annual program. Twelve ventures will participate ... and a professional network. All startups receive an entrepreneur coach, access to active ...
(Date:12/13/2018)... FREDERICK, Md. (PRWEB) , ... December 12, 2018 ... ... RFID and other life science software solutions, announces the Limfinity® ML (Machine Learning) ... to integrate trained machine learning models within Limfinity® solutions. In the module, trained ...
(Date:12/5/2018)... ... ... The incredible life story of former refugee and LG Sonic CEO Yousef ... the European Commissioner for Research and Innovation. , In his November 27th speech ... spoke at length of Yousef’s life and journey, citing the man who convinced him ...
Breaking Biology Technology:
(Date:12/27/2018)... , ... December 27, 2018 , ... ... cervical discs for implantation at its new Boston facility, and is now raising ... additional inventory to immediately expand market share against inferior ball and socket discs. ...
(Date:12/20/2018)... ... December 20, 2018 , ... ... and the completion of a new usability/observation room. This addition will help meet ... medical devices and drug delivery devices/combination products are safe and easy to use ...
(Date:12/18/2018)... ... , ... The nation’s leader in stem cell marketing, R3 ... been effective at reducing patient acquisition costs by over thirty percent. , For ... patient acquisition marketing programs. Traditional marketing for stem cell patients involves a considerable ...
Breaking Biology News(10 mins):